Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Kato

Showing results (11-20 of 640) with videos related to

Pageof 64
Sort By:
ESC Heart Failure|February 21, 2017
Validation of proposed risk stratification system for in-hospital cardiac complications in patients with takotsubo syndromeKen Kato, Yoshio Kobayashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 18, 2024
[History and Perspective of Chemotherapy in Advanced Esophageal Cancer]Kazuhiro Shiraishi, Ken Kato
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 13, 2019
[The forefront of preoperative adjuvant therapy for esophageal cancer]Masashi Ishikawa, Ken Kato
Japanese Journal of Clinical Oncology|July 7, 2016
Chemoradiotherapy for esophageal squamous cell cancerYusuke Sasaki, Ken Kato
Journal of Cardiology|February 27, 2018
Author's replyKen Kato, Yoshio Kobayashi
European Heart Journal. Quality of Care & Clinical Outcomes|January 1, 2019
Escape from the takotsubo octopus trap: liberation often temporary and readmission rates highKen Kato, Christian Templin
Physical Chemistry Chemical Physics : PCCP|January 13, 2021
Photogenerated carrier dynamics of TIPS-pentacene films as studied by photocurrent and electrically detected magnetic resonanceKen Kato, Yoshio Teki
Heart (British Cardiac Society)|April 28, 2022
β-blockers and outcomes of Takotsubo syndrome: need more clinical dataToshiaki Isogai, Ken Kato
Journal of Cardiology|July 30, 2017
Author's ReplyKen Kato, Yoshio Kobayashi
Japanese Journal of Clinical Oncology|March 29, 2019
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapyHidekazu Hirano, Ken Kato
Pageof 64

Showing results (11-20 of 640) with videos related to

Sort By:
Pageof 64
ESC Heart Failure|February 21, 2017
Validation of proposed risk stratification system for in-hospital cardiac complications in patients with takotsubo syndromeKen Kato, Yoshio Kobayashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 18, 2024
[History and Perspective of Chemotherapy in Advanced Esophageal Cancer]Kazuhiro Shiraishi, Ken Kato
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 13, 2019
[The forefront of preoperative adjuvant therapy for esophageal cancer]Masashi Ishikawa, Ken Kato
Japanese Journal of Clinical Oncology|July 7, 2016
Chemoradiotherapy for esophageal squamous cell cancerYusuke Sasaki, Ken Kato
Journal of Cardiology|February 27, 2018
Author's replyKen Kato, Yoshio Kobayashi
European Heart Journal. Quality of Care & Clinical Outcomes|January 1, 2019
Escape from the takotsubo octopus trap: liberation often temporary and readmission rates highKen Kato, Christian Templin
Physical Chemistry Chemical Physics : PCCP|January 13, 2021
Photogenerated carrier dynamics of TIPS-pentacene films as studied by photocurrent and electrically detected magnetic resonanceKen Kato, Yoshio Teki
Heart (British Cardiac Society)|April 28, 2022
β-blockers and outcomes of Takotsubo syndrome: need more clinical dataToshiaki Isogai, Ken Kato
Journal of Cardiology|July 30, 2017
Author's ReplyKen Kato, Yoshio Kobayashi
Japanese Journal of Clinical Oncology|March 29, 2019
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapyHidekazu Hirano, Ken Kato
Pageof 64